* Precigen Inc PGEN.OQ PGEN.O is expected to show a fall
in
quarterly revenue when it reports results on February 27
(estimated).
* The Germantown Maryland-based company is expected to
report a
74.4% decrease in revenue to $6.211 million from $24.22 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Precigen Inc is for
a
loss of 10 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Precigen
Inc is
$6.55, above its last closing price of $1.20.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.00 0.02 -0.04 Missed -340
Jun. 30 2022 -0.15 -0.13 -0.09 Beat 31.8
Mar. 31 2022 -0.14 -0.13 -0.10 Beat 21.6
Dec. 31 2021 -0.14 -0.14 -0.13 Beat 4.4
Sep. -0.15 -0.14 -0.15 Missed -5.9
30 2021
Jun. 30 2021 -0.13 -0.12 -0.10 Beat 20
Mar. 31 2021 -0.17 -0.16 -0.09 Beat 45.5
Dec. 31 2020 -0.21 -0.17 -0.23 Missed -32.7
This summary was machine generated February 24 at 19:11 GMT.
All figures in US dollars unless otherwise stated